Tandem Orthotopic Living Donor Liver Transplantation Followed by Same Donor Haploidentical Hematopoietic Stem Cell Transplantation for DOCK8 Deficiency: Tandem Liver and Bone Marrow Transplant in DOCK8 Deficiency.

BACKGROUND An 11-year old girl with DOCK8 deficiency was proposed for potentially curative hematopoietic stem cell transplantation (HSCT), the donor being her haploidentical mother. However, end-stage liver disease, caused by chronic Cryptosporidium infection required liver transplantation before HSCT. METHODS Consequently, a staged approach of a sequential liver transplant followed by a HSCT was planned, with her mother as the donor for both liver and HSCT. RESULTS The patient successfully underwent a left lobe orthotopic liver transplant, however, she developed a biliary leak delaying the HSCT. Notably, the recipient demonstrated 3 percent donor lymphocyte chimerism in her peripheral blood immediately prior to HSCT. Haploidentical related donor HSCT performed two months after liver transplantation was complicated by the development of acyclovir-resistant HSV viremia, primary graft failure, and sinusoidal obstruction syndrome (SOS). The patient died from SOS associated multiorgan failure with Candida sepsis on day +40 following HSCT. CONCLUSIONS We discuss the many considerations inherent to planning for HSCT preceded by liver transplant in patients with primary immunodeficiencies, including the role of prolonged immunosuppression and the risk of infection prior to immune reconstitution. We also discuss the implications of potential recipient sensitization against donor stem cells precipitated by exposure of the recipient to the donor lymphocytes from the transplanted organ.

[1]  William M. Lee,et al.  Herpes Simplex Virus–Associated Acute Liver Failure Often Goes Unrecognized , 2019, Hepatology.

[2]  R. Champlin,et al.  Delay of alternative antiviral therapy and poor outcomes of acyclovir‐resistant herpes simplex virus infections in recipients of allogeneic stem cell transplant – a retrospective study , 2018, Transplant international : official journal of the European Society for Organ Transplantation.

[3]  F. Tandoi,et al.  Successful Sequential Liver and Hematopoietic Stem Cell Transplantation in a Child With CD40 Ligand Deficiency and Cryptosporidium-Induced Liver Cirrhosis , 2018, Transplantation.

[4]  D. Porter,et al.  Toward dual hematopoietic stem-cell transplantation and solid-organ transplantation for sickle-cell disease. , 2018, Blood advances.

[5]  N. Rastogi,et al.  Reduced‐toxicity alternate‐donor stem cell transplantation with posttransplant cyclophosphamide for primary immunodeficiency disorders , 2018, Pediatric blood & cancer.

[6]  I. Tezcan,et al.  Successful hematopoietic stem cell transplantation after myeloablative conditioning in three patients with dedicator of cytokinesis 8 deficiency (DOCK8) related Hyper IgE syndrome , 2018, Bone Marrow Transplantation.

[7]  D. Gladstone,et al.  HLA donor-specific antibodies in allogeneic hematopoietic stem cell transplantation: challenges and opportunities. , 2017, Hematology. American Society of Hematology. Education Program.

[8]  Yu-Hong Chen,et al.  Risk factors for herpes simplex virus-1/2 viremia and clinical outcomes following unmanipulated haploidentical haematopoietic stem cell transplantation. , 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[9]  M. Yılmaz,et al.  Hematopoietic stem cell transplantation from unrelated donors in children with DOCK8 deficiency , 2017, Pediatric transplantation.

[10]  Thomas E. Hughes,et al.  Haploidentical Related Donor Hematopoietic Stem Cell Transplantation for Dedicator-of-Cytokinesis 8 Deficiency Using Post-Transplantation Cyclophosphamide. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[11]  P. Richardson,et al.  Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND Study. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[12]  A. Hawwari,et al.  Novel mutation in DOCK8-HIES with severe phenotype and successful transplantation. , 2017, Clinical immunology.

[13]  E. Fuchs Related haploidentical donors are a better choice than matched unrelated donors: Point. , 2017, Blood advances.

[14]  Thomas E. Hughes,et al.  Haploidentical related donor hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for DOCK8 deficiency. , 2016, The journal of allergy and clinical immunology. In practice.

[15]  Douglas R. McDonald,et al.  Hematopoietic stem cell transplantation outcomes for 11 patients with dedicator of cytokinesis 8 deficiency. , 2016, The Journal of allergy and clinical immunology.

[16]  M. Abecassis,et al.  Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation , 2016, Bone Marrow Transplantation.

[17]  Elias T. Zambidis,et al.  Alternative-Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Nonmalignant Disorders. , 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[18]  T. Kawai,et al.  Combined Bone Marrow and Kidney Transplantation for the Induction of Specific Tolerance , 2016, Advances in hematology.

[19]  R. D'Agostino,et al.  Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure. , 2016, Blood.

[20]  T. Fleisher Transplantation Outcomes for Severe Combined Immunodeficiency 2000–2009 , 2015, Pediatrics.

[21]  S. Solomon,et al.  Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[22]  H. Kong,et al.  Matched related and unrelated donor hematopoietic stem cell transplantation for DOCK8 deficiency. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[23]  J. Orange,et al.  DOCK8 Deficiency: Clinical and Immunological Phenotype and Treatment Options - a Review of 136 Patients , 2015, Journal of Clinical Immunology.

[24]  J. Crawford,et al.  Sinusoidal obstruction syndrome (hepatic veno-occlusive disease). , 2014, Journal of Clinical and Experimental Hepatology.

[25]  M. Gobbi,et al.  Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[26]  L. Notarangelo,et al.  Transplantation outcomes for severe combined immunodeficiency, 2000-2009. , 2014, The New England journal of medicine.

[27]  S. Solomon,et al.  T-cell replete haploidentical donor transplantation using post-transplant CY: an emerging standard-of-care option for patients who lack an HLA-identical sibling donor , 2014, Bone Marrow Transplantation.

[28]  A. Borkhardt,et al.  Haploidentical stem cell transplantation in DOCK8 deficiency - Successful control of pre-existing severe viremia with a TCRaß/CD19-depleted graft and antiviral treatment. , 2014, Clinical immunology.

[29]  R. Nelson,et al.  Recent Advances in Transplantation for Primary Immune Deficiency Diseases: A Comprehensive Review , 2014, Clinical Reviews in Allergy & Immunology.

[30]  D. Sachs,et al.  Tolerance induction: hematopoietic chimerism , 2013, Current opinion in organ transplantation.

[31]  D. Sachs,et al.  Lack of antidonor alloantibody does not indicate lack of immune sensitization: studies of graft loss in a haploidentical hematopoietic cell transplantation swine model. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[32]  Douglas B. Johnson,et al.  How can we reduce hepatic veno-occlusive disease-related deaths after allogeneic stem cell transplantation? , 2012, Experimental hematology.

[33]  A. Woolfrey,et al.  Hematopoietic cell transplantation for treatment of primary immune deficiencies. , 2010, Cellular therapy and transplantation.

[34]  Allen R. Chen,et al.  Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[35]  S. Holland,et al.  Combined immunodeficiency associated with DOCK8 mutations. , 2009, The New England journal of medicine.

[36]  H. Friess,et al.  Herpes simplex virus sepsis and acute liver failure , 2009, Clinical transplantation.

[37]  L. Notarangelo,et al.  Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needs. , 2008, The Journal of allergy and clinical immunology.

[38]  B. Portmann,et al.  Liver disease in children with primary immunodeficiencies. , 2001, The Journal of pediatrics.

[39]  T. Lion,et al.  Successful stem cell transplantation following orthotopic liver transplantation from the same haploidentical family donor in a girl with hemophagocytic lymphohistiocytosis , 2000 .

[40]  G. Mufti,et al.  Correction of the hyper-IgM syndrome after liver and bone marrow transplantation. , 2000, The New England journal of medicine.

[41]  K. Ishak,et al.  Recurring fibro-obliterative venopathy in liver allografts. , 1999, The American journal of surgical pathology.

[42]  T. Starzl,et al.  Cell migration and chimerism after whole‐organ transplantation: The basis of graft acceptance , 1993, Hepatology.

[43]  N. Callander,et al.  Pilot trial of prophylactic ursodiol to decrease the incidence of veno-occlusive disease of the liver in allogeneic bone marrow transplant patients. , 1992, Bone marrow transplantation.

[44]  R. Storb,et al.  Successful allogeneic bone marrow transplantation in a 6.5-year-old male for severe aplastic anemia complicating orthotopic liver transplantation for fulminant non-A-non-B hepatitis. , 1991, Blood.